The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia

被引:38
作者
Lauzier, Francois [3 ,4 ]
Ruest, Annie [4 ,5 ]
Cook, Deborah [3 ,5 ]
Dodek, Peter [6 ]
Albert, Martin [7 ]
Shorr, Andrew F. [8 ]
Day, Andrew [1 ]
Jiang, Xuran [1 ]
Heyland, Daren [1 ,2 ]
机构
[1] Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON K7L 2V7, Canada
[2] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada
[3] McMaster Univ, Dept Med, Hamilton, ON, Canada
[4] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada
[5] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[6] Univ British Columbia, St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V5Z 1M9, Canada
[7] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
[8] Washington Hosp Ctr, Washington, DC 20010 USA
基金
加拿大健康研究院;
关键词
clinical pulmonary infection score; pretest probability; pneumonia;
D O I
10.1016/j.jcrc.2008.01.006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The aim of the study was to assess the utility of pretest probability and modified clinical pulmonary infection score CPIS in the diagnosis of late-onset ventilator-associated pneumonia (VAP). Materials and Methods: In 740 adults enrolled in a multicenter randomized trial, intensivists prospectively rated the pretest probability of VAP as low, moderate, or high based on their clinical judgment. The modified CPIS was calculated without considering culture results. Ventilator-associated pneumonia diagnosis was determined by 2 adjudicators using standardized definitions. We analyzed the relationship between pretest likelihood, CPIS, and VAP diagnosis. Results: Among the 739 patients analyzed, 14.5%, 39.6%, and 45.9% had low, moderate, and high pretest probability of VAP. Patients with high pretest probability had a lower PaO2/FiO(2) ratio and a larger volume of secretions. High or moderate vs low pretest probability had high sensitivity (0.88; 95% confidence interval [CI], 0.87-0.89) and positive predictive value (0.87; 95% CI, 0.86-0.88) but low specificity (0.27; 95% CI, 0.21-0.35) and negative predictive value (0.29; 95% C,: 0.22-0.37) for the diagnosis of VAP. Therefore, 71% of patients who had a low pretest probability were actually infected (1 - negative predictive value). The area under the receiver operating characteristic curve for the modified CPIS was not significant (0.47; 95% CI, 0.42-0.53), meaning that no score threshold was clinically useful. Conclusions: Pretest probability and a modified CPIS, which excludes culture results, are of I imited utility in the diagnosis of late-onset VAP. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 50 条
  • [31] Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults
    Rotstein, Coleman
    Evans, Gerald
    Born, Abraham
    Grossman, Ronald
    Light, R. Bruce
    Magder, Sheldon
    McTaggart, Barrie
    Weiss, Karl
    Zhanel, George G.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2008, 19 (01) : 19 - 53
  • [32] Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator - Associated Pneumonia
    Chen, Changqin
    Yan, Molei
    Hu, Caibao
    Lv, Xiaochun
    Zhang, Huihui
    Chen, Shangzhong
    M S-MEDECINE SCIENCES, 2018, 34 : 26 - 32
  • [33] EPIDEMIOLOGY AND CLINICAL FEATURES OF VENTILATOR-ASSOCIATED TRACHEITIS AND PNEUMONIA IN A PEDIATRIC POPULATION
    Maurice, S. A.
    Tougas, C.
    Pringle, C.
    Mehra, S.
    Carr, S.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [34] Ventilator-associated pneumonia: epidemiology and impact on the clinical evolution of ICU patients
    de Azambuja Rodrigues, Pedro Mendes
    do Carmo Neto, Edgard
    de Carneiro Santos, Luiz Rodrigo
    Knibel, Marcos Freitas
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (11) : 1084 - 1091
  • [35] Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia
    Kollef, Morin H.
    Morrow, Lee E.
    Niederman, Michael S.
    Leeper, Kenneth V.
    Anzueto, Antonio
    Benz-Scott, Lisa
    Rodino, Frank J.
    CHEST, 2006, 129 (05) : 1210 - 1218
  • [36] Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection
    Wongsurakiat, Phunsup
    Tulatamakit, Sirapat
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [37] Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia
    Iregui, M
    Ward, S
    Sherman, G
    Fraser, VJ
    Kollef, MH
    CHEST, 2002, 122 (01) : 262 - 268
  • [38] Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia
    Delisle, Marie-Soleil
    Williamson, David R.
    Albert, Martin
    Perreault, Marc M.
    Jiang, Xuran
    Day, Andrew G.
    Heyland, Daren K.
    CANADIAN RESPIRATORY JOURNAL, 2011, 18 (03) : 131 - 136
  • [39] Clinical review: Non-antibiotic strategies for preventing ventilator-associated pneumonia
    Ferrer, R
    Artigas, A
    CRITICAL CARE, 2002, 6 (01): : 45 - 51
  • [40] Procalcitonin and clinical pulmonary infection score as predictors of stroke-associated pneumonia: a prospective observational study
    Elgazzar, Alaa E. M.
    Elkhateeb, Takwa H.
    Hosny, Hanaa
    Fouda, Ahmed Y.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2019, 68 (03): : 363 - 370